Menu

Top Stories

Published on Thursday, April 11, 2019

Moderated discussion: “Advancing the innovation ecosystem: Working together for patients,” in Washington, DC

Moderated discussion: “Advancing the innovation ecosystem: Working together for patients,” in Washington, DC

On April 3, 2019, Francis Collins, MD, PhD, director of the National Institutes of Health (NIH), Mikael Dolsten, MD, PhD, chief scientific officer and president, Worldwide Research, Development and Medical, Pfizer, joined in a discussion led by Susan Dentzer, visiting fellow at the Robert J. Margolis Center for Health Policy, Duke University, in Washington DC.

Photo: Francis Collins, MD, PhD, director of the NIH (left) and author Alejandro Hernandez, editorial manager of the Alpha-1 Foundation (right)

For 60 minutes, Collins, Dolsten, and Dentzer engaged in a conversation with the theme of: “Advancing the innovation ecosystem: working together for patients,” where they emphasized the need for continued collaboration between the private and public sectors, along with the patient community, in order to advance new and emerging technologies and innovative approaches for potentially life-saving treatments and new outcomes in medicine.

“We are currently living in remarkable times with amazing things happening in areas such as cancer immuno-therapy, gene therapy, and gene editing. The things that are happening right now, I had no idea they would even be possible just five or six years ago,” expressed Collins when asked about the current position “the ecosystem,” as they described the collaboration between the private and public sectors with small biotech companies; an ecosystem with symbiotic characteristics where all contributors play an important role in a tremendous team effort, in medical research.

Collins and Dolsten agreed on the importance of advocacy groups and organizations as well as the patient community, in being part of the process for better outcomes and the ability to bring new and potential treatments for various conditions to the clinic, including rare diseases, such as Alpha-1 Antitrypsin Deficiency (Alpha-1). 

“We need you, the patient community, you are the reason we have gotten this far,” said Collins.

“One of the most important resources needed for this ecosystem to strive is you, the patient. We need to line-up our resources and keep the ecosystem going, including the patient community. There is no one better to bring together what others (physicians) can do than patients: you inspire all of us,” expressed Dolsten.

The Alpha-1 Foundation applauds and supports these types of initiatives, in which patients become partners and are of vital importance for therapeutic development. 

The panel also mentioned that it is critical to spread awareness and education in the medical community, and being able to have early diagnosis and detection, while mentioning the Accelerating Medicines Partnership (AMP), a public-private partnership between the NIH, the U.S. Food and Drug Administration (FDA), multiple biopharmaceutical, and life science companies, as well as non-profit organizations to transform the current model for developing new diagnostics and treatments by jointly identifying and validating promising biological targets for therapeutics.

The ultimate goal of AMP is to increase the number of new diagnostics and therapies for patients and reduce the time and cost of developing them.

“Patient participation is critical for AMP, especially to remind us what we are doing and why-and-who we are doing it for,” said Collins, who also mentioned the Foundation for the National Institutes of Health (FNIH) as being instrumental in bringing together funds and resources from both the private and public sectors, to work in mutual collaboration in research projects that will ultimately benefit the patient community.

The Alpha-1 Foundation applauds these types of initiatives that support research and bring innovative approaches to the table for the benefit of the patient community, as we are committed to finding a cure for Alpha-1 and improving the lives of Alphas, and those affected by the condition, worldwide.

For more information, please visit the Collaboration Ecosystem website and the AMP website.


Print

For Jack Davis, “Music is my happy place”

Friday, March 16, 2012
How to deal with a chronic condition like Alpha-1 lung disease? Jack Davis Jr, 61, does it by keeping a positive outlook on life – and singing and playing in his country rock band. Davis lives in Birmingham AL, but was born in the small...
Divider

Jaidan’s second chance

Friday, March 16, 2012
Her mother calls it her lifeline – the 10 inch scar across her 21-month-old daughter’s tiny belly that marks the moment when she received the gift of life. “It to me defines a part of her life. It definitely shows that...
Divider

An Information Web Site Run By and For Pulmonary Patients

Friday, March 16, 2012
Jane Martin, BA, CRT is a respiratory therapist who is making great strides for pulmonary patients with her web site titled “Breathing Better, Living Well” (or BBLW, as Martin and frequent viewers like to call it). Martin...
Divider

Breathless Journey

Friday, March 16, 2012
Jim Danley grew up in Niles, Michigan, and eventually moved to Florida, where he studied hospitality management. He then married Nancy, and began a family. He worked in hotels for 15 years, and then one day decided he’d had enough....
Divider

His wings lifted him way above his depression

Friday, March 16, 2012
If you saw the movie, The Bucket List, you probably enjoyed watching Morgan Freeman and Jack Nicholson trying to do as many outrageous and unthinkable things as they could before their time was up - but what if it was your life? What would...
Divider

Go, Dad, Go!

Friday, March 16, 2012
John Kelley tackles the grueling Ironman competition to raise money and awareness for Alpha-1, all for his sons and the Alpha-1 community he loves so much. He battled the Pacific seas, gusty winds, and the stifling heat of the lava fields. But...
Divider

John Taylor: No mountain’s too high now

Friday, March 16, 2012
On a sunny day in July, John Taylor hiked along the Continental Divide, reaching 12,005 feet, where the air is too thin for trees to grow. He looked at the mountainside, dotted with specs of color from hardy wildflowers. He took a deep breath,...
Divider

“One of the Originals” Retires from AlphaNet

Friday, March 16, 2012
Joyce Finch has retired after more than a decade with AlphaNet, and although she does it with regret, she’s had more than her share of medical challenges in recent years. “It’s just time,” she says. One of the first...
Divider

Juan Pino, 9/11 Survivor

Friday, March 16, 2012
At 40, Juan Pino was a man who knew how to live: he got up at six every morning, summer and winter, and ran six miles before breakfast, he took a long train ride from his home in Yonkers into New York’s Grand Central Station every...
Divider

Moving Forward

Friday, March 16, 2012
As a child, Barden had asthma, and her family’s smoking made it worse – by age 10, she had decided she would never smoke, “even though I couldn’t verbalize it as a child, I managed to refuse to buy my mother...
Divider

I hope you dance: the story of Kaitlin’s wedding

Friday, March 16, 2012
Lace-wrapped potpourri, heart-shaped soap and picture frames are among the most popular wedding favors, but for their wedding, Kaitlin Boyd and Patrick Kelly of Long Island, NY, wanted keepsakes that would make a lasting impression. So they...
Divider

Team Player

Friday, March 16, 2012
While it’s not unusual to work out with equipment at a gym, that equipment is rarely an oxygen tank: but for Karen Erickson, a biotech employee from Thousand Oaks, California, strapping on that tank lets her push herself to the...
Divider
First61626364656667686970

Article Search

Enter keywords in text box and click Search button for results.

Archive